melatonin has been researched along with fluvoxamine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Durlach-Misteli, C; Van Ree, JM | 1 |
| Den Boer, JA; Westenberg, HG | 1 |
| Althoff, PH; Bochnik, HJ; Demisch, K; Demisch, L; Nickelsen, T; Rieth, R; Schöffling, K | 1 |
| Demisch, K; Demisch, L; Nickelsen, T; Rieth, R | 1 |
| Demisch, K; Demisch, L; Gerbaldo, H | 1 |
| Arendt, J; Bojkowski, CJ; Skene, DJ | 1 |
| Barash, I; Jahjah, N; Mizruhin, A; Odnopozov, N; Silver, H | 1 |
| Grözinger, M; Härtter, S; Hiemke, C; Röschke, J; Weigmann, H | 1 |
| Bertilsson, L; Röjdmark, S; Tybring, G; Ursing, C; von Bahr, C; Yasui, N | 1 |
| Grözinger, M; Härtter, S; Hiemke, C; Röschke, J; Rose, DM; Wang, X | 1 |
| Arand, M; Friedberg, T; Härtter, S; Hiemke, C; Oesch, F; Wang, X; Weigmann, H | 1 |
| Facciolá, G; Hidestrand, M; Tybring, G; von Bahr, C | 1 |
| Ekstrom, RD; Golden, RN; Lydiard, RB; Mason, GA; Miller, HL | 1 |
| Altschuler, EL; Kast, RE | 1 |
| Barton, R | 1 |
| Weber, K | 1 |
| Katayama, Y; Katsura, K; Nishiyama, Y; Otori, T; Sunami, E; Usuda, K | 1 |
| Ioannides, C; Papagiannidou, E; Skene, DJ | 1 |
| Anderson, GM | 1 |
| Hooper, PL | 1 |
2 review(s) available for melatonin and fluvoxamine
| Article | Year |
|---|---|
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
Asperger's syndrome: from hiding to thriving.
Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Depressants; Child; Child Behavior; Diagnosis, Differential; Early Diagnosis; Fluvoxamine; Humans; Interpersonal Relations; Melatonin; Nurse Practitioners; Nursing Assessment; Olanzapine; Prevalence; Primary Health Care; Prognosis; Psychological Tests; Psychology, Child; Risperidone; Serotonin Agents; Social Behavior; United States | 2008 |
6 trial(s) available for melatonin and fluvoxamine
| Article | Year |
|---|---|
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin | 1990 |
Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.
Topics: Adult; Analysis of Variance; Desipramine; Fluvoxamine; Humans; Hydrocortisone; Male; Melatonin; Radioimmunoassay | 1994 |
Increased bioavailability of oral melatonin after fluvoxamine coadministration.
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Area Under Curve; Biological Availability; Cytochrome P-450 CYP2D6; Fluvoxamine; Half-Life; Humans; Male; Melatonin; Middle Aged; Reference Values; Selective Serotonin Reuptake Inhibitors | 2000 |
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Fluvoxamine; Humans; Hydroxylation; Male; Melatonin; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors | 2000 |
Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Fluvoxamine; Humans; Imipramine; Melatonin; Norepinephrine; Pineal Gland; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depression; Female; Fluvoxamine; Humans; Male; Melatonin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Stroke | 2012 |
14 other study(ies) available for melatonin and fluvoxamine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Melatonin; Mianserin; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine; Sensitivity and Specificity | 1992 |
Melatonin and cortisol increase after fluvoxamine.
Topics: Adult; Antidepressive Agents; Circadian Rhythm; Fluvoxamine; Humans; Hydrocortisone; Male; Melatonin; Oximes; Serotonin Antagonists | 1986 |
The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Blood Platelets; Circadian Rhythm; Female; Fluvoxamine; Humans; Male; Melatonin; Monoamine Oxidase; Osmolar Concentration; Oximes; Serotonin; Time Factors; Tranylcypromine | 1987 |
Fluvoxamine-melatonin-stimulation-test (FMST) in patients with depressive disorders.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Dexamethasone; Female; Fluvoxamine; Humans; Male; Melatonin; Middle Aged; Oximes | 1988 |
Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
Topics: Adult; Biomarkers; Chronic Disease; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fluvoxamine; Humans; Male; Melatonin; Psychiatric Status Rating Scales; Schizophrenia; Selective Serotonin Reuptake Inhibitors | 1996 |
Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
Topics: Circadian Rhythm; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hydrocortisone; Melatonin; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2000 |
Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.
Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP1A2; Enzyme Inhibitors; Fluvoxamine; Humans; Melatonin; Microsomes, Liver; Serotonin; Theophylline | 2001 |
Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.
Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Melatonin; Microsomes, Liver; Selective Serotonin Reuptake Inhibitors; Substrate Specificity | 2001 |
Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.
Topics: Adjuvants, Immunologic; Administration, Oral; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP1A2 Inhibitors; Drug Combinations; Fluvoxamine; Humans; Interleukin-2; Liver; Lymphocytes; Melatonin; Models, Biological; Receptors, Melatonin | 2006 |
Potential drug interactions with melatonin.
Topics: 5-Methoxypsoralen; Acetaminophen; Analgesics, Non-Narcotic; Animals; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Central Nervous System Depressants; Diazepam; Drug Interactions; Estrogens; Fluvoxamine; Humans; Hypnotics and Sedatives; Male; Melatonin; Methoxsalen; Microsomes, Liver; Middle Aged; Rats, Wistar; Tamoxifen | 2014 |
Fluvoxamine, melatonin and COVID-19.
Topics: Clinical Deterioration; COVID-19; Fluvoxamine; Humans; Melatonin; Outpatients; SARS-CoV-2 | 2021 |
Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19.
Topics: COVID-19 Drug Treatment; Fluvoxamine; Heme Oxygenase (Decyclizing); Humans; Melatonin; SARS-CoV-2 | 2022 |